CFDA Updates

December 2, 2017

CFDA Approves ORTHO VISION Platform for Blood Transfusion

Ortho Clinical Diagnostics announced that its ORTHO VISION Platform of fully automated blood analyzers for low-, mid- and high-volume transfusion medicine laboratories has received approval by the CFDA. The platform […]
November 28, 2017

EYE TECH CARE’s Glaucoma Treatment Product Receives CFDA Approval

EYE TECH CARE, a French medical device company, has received approval from CFDA to begin marketing its EyeOP1® glaucoma treatment product in China. The first non-invasive medical device approved for […]
November 27, 2017

Registration is open! Meeting CFDA Representatives from Medical Device Evaluation Center in Boston.

China Med Device cordially invites you to our latest regulatory event in Boston on December 10th, 2017 and the opportunity to meet face to face with two prominent China FDA […]
November 22, 2017

CryoLife’s BioGlue® Clinical Trial Is Underway In China

CryoLife, a US-based medical device and tissue processing company focused on cardiac and vascular surgery, announced that enrollment has started in the company’s BioGlue clinical trial in China.  The results […]
November 22, 2017

BREAKING NEWS: CFDA Is Proposing 6 Major Changes to Its Medical Device Regulations

CFDA just released a Solicitation for Public Comments (SPC) for its proposed amendment of the Medical Device Regulations (MDR), as mandated by a recent order from the Chinese State Council. […]